Atlas Trials

Convalescent Plasma as Adjunct Therapy for COVID-19

Clinical trial NCT04873414 · UNKNOWN

Trial details

NCT number
NCT04873414
Sponsor
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-12-01
Primary completion
2021-10-30
Enrollment
364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.